- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Sanitation.
Displaying page 1 of 1.
EudraCT Number: 2014-003024-46 | Sponsor Protocol Number: Repha_1412 | Start Date*: 2014-09-19 | ||||||||||||||||
Sponsor Name:Repha GmbH | ||||||||||||||||||
Full Title: Efficacy, safety and tolerability of Angocin Anti-Infekt N versus Placebo for MRSA eradication | ||||||||||||||||||
Medical condition: MRSA colonisation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-000842-23 | Sponsor Protocol Number: AdAM_2017 | Start Date*: 2018-02-19 |
Sponsor Name:Medical University Innsbruck | ||
Full Title: Adjuvante Imiquimod Therapie zur Senkung der Rezidivrate nach operativer Therapie bei analen HPV-Läsionen | ||
Medical condition: anal HPV-lesions | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2008-004639-39 | Sponsor Protocol Number: CYT003-QbG10 09 | Start Date*: 2008-10-03 | |||||||||||
Sponsor Name:Cytos Biotechnology AG | |||||||||||||
Full Title: Double-blind, Placebo-controlled Dose-finding Study with CYT003-QbG10 in Adult Patients with Rhinoconjunctivitis due to House Dust Mite Allergy. | |||||||||||||
Medical condition: Adult patients with perennial allergic rhinoconjunctivitis due to house dust mite | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Completed) DE (Completed) LV (Completed) LT (Completed) GR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-003454-29 | Sponsor Protocol Number: CYT005-AllQbG10 04 | Start Date*: 2007-10-19 | |||||||||||
Sponsor Name:Cytos Biotechnology AG | |||||||||||||
Full Title: Double-blind, Placebo-controlled Study to Investigate Safety, Tolerability, Immunogenicity and Clinical Efficacy of a Specific Immuotherapy Combining Allergen with CYT003-QbG10 (CYT005-AllQbG10) in... | |||||||||||||
Medical condition: Adult patients with perennial allergic rhinoconjunctivitis due to house dust mite allergy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
